01Month
-
2024
-
2023
12Month
11Month
07Month
04Month
-
2022
-
2021
09Month
09Month Subsidiary Coning Biotech obtained the exclusive distributor of "Techlab Diagnostic Products" in Taiwan
06Month
-
2020
09Month Subsidiary Genconn Biotech obtained the exclusive agent of Ambry Genetics, an internationally renowned genetic testing company, in Taiwan
03Month Innovative introduction of personal health examination recommendation system
-
2019
08Month
06Month Subsidiary Coning Biotech began to promote the automated test tube management system
04Month Subsidiary Genconn Biotech obtained the exclusive agent of Guardant Health, an internationally renowned cancer liquid biopsy company, in Taiwan.
02Month
-
2018
08Month
-
2017
11Month Listed at emerging stock market
09Month Acquired 100% stock ownership of Kangyi Technology Co., Ltd.
07Month Acquired 100% stock ownership of Kangyi Technology Co., Ltd.
04Month Introduced comprehensive membership services.
04Month
03Month Subsidiary Shenzhen Healthconn Technology Co., Ltd. obtains 100% equity of Zhengzhou Yongyang Testing Service Co., Ltd.
02Month Established subsidiary, Genconn Bio Co., Ltd.
-
2016
02Month
-
2015
08Month Established Shenzhen Healthconn Limited.
07Month Increased capital in Healthconn Limited by HKD 700,000.
07Month Increased capital in Healthconn Corp. by USD 100,000.
04Month Established Healthconn Limited (HK)
03Month Established Healthconn Corp. (KY)
-
2014
10Month
10Month
-
2010
11Month Promoted the H-Gene plan to integrate whole genome sequencing in innovative personal health management services, thereby innovating the model in global health industry.
06Month Introduced world-class high throughput sequencer that performs whole genome sequencing and deciphers the ultimate code to individualized medical and health management.
-
2009
04Month
02Month
01Month